APA (7th ed.) Citation

A, J., K, R., JA, S., HM, G., PA, F., SP, K., . . . CL, L. (2008). Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB). Cancer, 113(4), 847. https://doi.org/10.1002/cncr.23621

Chicago Style (17th ed.) Citation

A, Jatoi, et al. "Tetracycline to Prevent Epidermal Growth Factor Receptor Inhibitor-induced Skin Rashes: Results of a Placebo-controlled Trial from the North Central Cancer Treatment Group (N03CB)." Cancer 113, no. 4 (2008): 847. https://doi.org/10.1002/cncr.23621.

MLA (9th ed.) Citation

A, Jatoi, et al. "Tetracycline to Prevent Epidermal Growth Factor Receptor Inhibitor-induced Skin Rashes: Results of a Placebo-controlled Trial from the North Central Cancer Treatment Group (N03CB)." Cancer, vol. 113, no. 4, 2008, p. 847, https://doi.org/10.1002/cncr.23621.